International Journal of Biomedicine. 2021;11(2):212-215.
Originally published June 5, 2021
Background: The purpose of our work was determined by the accumulation of a significant amount of experimental material under the conditions of implantation of a foreign body, a mesh implant, into the region of the anterior abdominal wall in order to obtain experimental inflammation, in which foreign body giant cells (FBGCs) were constantly visualized as reactive formations. This research aimed to study the dynamics of morphological changes in FBGCs under conditions of experimental implantation of a foreign body, a mesh implant, and the possible mechanism of their formation
Methods and Results: This study was carried out on male Wistar rats, in which a foreign body was implanted—a mesh endoprosthesis made of polypropylene—in the region of the anterior abdominal wall under the aponeurosis of the rectus abdominis muscles. A section of the anterior abdominal wall with the implanted endoprosthesis was excised on Days 10, 21, 30, and 60 after surgery, fixed in 10% buffered formalin solution. The obtained samples were embedded in paraffin according to standard prescriptions; histological sections with a thickness of 5-7µm were made and stained with H&E, according to the methods of Van Gieson and Mallory, and an immunohistochemical study was performed using the marker of cell proliferation (Ki-67). The revealed structural features of multinucleated cells were recorded by microphotography using a photo attachment and a Levenhuk video camera (USA).
During the study, it was revealed that the amount, functional activity and morphological diversity of FBGCs gradually increased, reaching a maximum by Day 30 of the experiment. At a later date, some of them died, while the remaining part was differentiated, splitting into small multinucleated cells and mononuclear elements, morphologically identical to macrophages and fibroblasts. The formation of FBGCs continued as long as the mesh implant was in the body.
Conclusion: FBGCs are reactive formations that arise in response to various endo- and exogenous irritation.
1. Dolzhikov AA, Kolpakov AYa, Yarosh AL, Molchanova AS, Dolzhikova IN. [Giant foreign body cells and tissue reactions on on the surface of implants]. Kursk scientific and practical bulletin "Man and His health". 2017; (3): 86-94. [Article in Russian].
2. Zatolokina MA, Kuznetsov SL, Mutova TV, Mishina ES, Zatolokina ES. [Morphology of multinucleated giant cells in different types of stimulation to reparative regeneration in hernioplasty]. Pathogenesis. 2018; 16(4): 19-27. DOI: 10.25557/2310-0435.2018.04.19-27. [Article in Russian].
3. Brodbeck WG, Macewan M, Colton E, Meyerson H, Anderson JM. Lymphocytes and the foreign body response: lymphocyte enhancement of macrophage adhesion and fusion. J Biomed Mater Res A. 2005 Aug 1;74(2):222-9. doi: 10.1002/jbm.a.30313.
4. Brodbeck WG, Anderson JM. Giant cell formation and function. Curr Opin Hematol. 2009 Jan;16(1):53-7. doi: 10.1097/MOH.0b013e32831ac52e.
5. Elchaninov AV, Fatkhudinov TKh., Usman NY, Kananykhina EY, Arutyunyan IV, Makarov AV, Lokhonina AV, Eremina IZ, Surovtsev VV, Goldshtein DV, Bolshakova GB, Glinkina VV, Sukhikh GT. [Dynamics of macrophage populations of the liver after subtotal hepatectomy in rats]. BMC Immunology. 2018; 19(1): 23. [Article in Russian].
6. Kastellorizios M, Tipnis N, Burgess DJ. Foreign Body Reaction to Subcutaneous Implants. Adv Exp Med Biol. 2015;865:93-108. doi: 10.1007/978-3-319-18603-0_6.
7. Kirk JT, McNally AK, Anderson JM. Polymorphonuclear leukocyte inhibition of monocytes/macrophages in the foreign body reaction. J Biomed Mater Res A. 2010 Sep 1;94(3):683-7. doi: 10.1002/jbm.a.32682.
8. Perdiguero EG, Geissmann F. The development and maintenance of resident macrophages. Nat Immunol. 2016 Jan;17(1):2-8. doi: 10.1038/ni.3341.
9. You Q, Holt M, Yin H, Li G, Hu CJ, Ju C. Role of hepatic resident and infiltrating macrophages in liver repair after acute injury. Biochem Pharmacol. 2013 Sep 15;86(6):836-43. doi: 10.1016/j.bcp.2013.07.006.
©2021 International Medical Research and Development Corporation.